[Chemical structures and pharmacological characteristics of novel non-thiazolidinedione insulin sensitizer (JTT-501, FK614)].
Yamanouchi
Toshikazu
T
Department of Internal Medicine, School of Medicine, University of Teikyo.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D007333:Insulin Resistance; D007555:Isoxazoles / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D050356:Lipid Metabolism; D010069:Oxadiazoles / Q000009:adverse effects; D011972:Receptor, Insulin / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D013844:Thiazoles / Q000737:chemistry; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000378:metabolism
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007555:Isoxazoles; D010069:Oxadiazoles; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; C406084:YM 440; C089946:2,4-thiazolidinedione; D011972:Receptor, Insulin; C112329:JTT 501